期刊文献+

miR-34b和miR-155在膀胱尿路上皮癌中的表达及意义 被引量:3

Expression and significance of miR-34b and miR-155 in bladder urothelial carcinoma
下载PDF
导出
摘要 目的:检测miR-34b和miR-155在膀胱尿路上皮癌中的表达,分析其在不同临床病理特征中的表达差别。方法:选取2014年1月至2016年1月我院收治的79例膀胱尿路上皮癌患者为观察组,选取距肿物边缘>3 cm的正常膀胱黏膜组织52例作为对照组,应用实时荧光定量PCR法检测两组中miR-34b和miR-155的表达情况。结果:两组中miR-34b和miR-155的表达差别有统计学意义,观察组中miR-34b和miR-155的表达在不同病变级别、是否浸润、脉管癌栓、淋巴结转移及TNM分期的表达中差别有统计学意义。观察组中miR-34b的表达与增殖指数间呈负相关性,miR-155的表达与增殖指数间呈正相关性。生存分析显示二者的表达与生存时间有关。结论:膀胱尿路上皮癌组织中miR-34b低表达、miR-155高表达,对病变的形成和进展有重要的促进作用。二者对肿瘤的作用可能与对细胞增殖的促进作用有关。术后检测miR-34b和miR-155的表达对判断预后可能有一定价值。 Objective:To detect the expression of miR-34 b and miR-155 in bladder urothelial carcinoma,analyze the difference of miR-34 b and miR-155 expression in different clinicopathological features.Methods:79 patients with bladder urothelial carcinoma were selected as the observation group from January 2014 to January 2016.52 patients with normal bladder mucosa tissues(from the edge of the tumor>3 cm)were selected as the control group.Expression of miR-34 b and miR-155 were detected in the two groups by real-time fluorescence quantitative PCR.Results:The expression of miR-34 b and miR-155 was statistically significant in two groups.The expression of miR-34 b and miR-155 was statistically significant in different pathological grades,infiltration depth,vascular tumor thrombus,lymph node metastasis and TNM staging in observation group.The expression of miR-34 b was negatively correlated with the proliferation index,while the expression of miR-155 was positively correlated with the proliferation index.Expression of miR-34 b and miR-155 were related to survival time by survival analysis.Conclusion:The lower expression of miR-34 b and the higher expression of miR-155 play an important role in bladder urothelial carcinoma.miR-34 b and miR-155 may be related to cell proliferation.Detection of miR-34 b and miR-155 expression may have certain value in judging prognosis.
作者 邱实 何龙 陈鹏 李健 郭时英 杨宏伟 Qiu Shi;He Long;Chen Peng;Li Jian;Guo Shiying;Yang Hongwei(Department of Urology,Northern Theater Command General Hospital,Liaoning Shenyang 110016,China)
出处 《现代肿瘤医学》 CAS 2020年第11期1899-1902,共4页 Journal of Modern Oncology
基金 辽宁省科学技术计划项目(编号:2013225220)。
关键词 膀胱 尿路上皮癌 miR-34b MIR-155 预后 bladder urothelial carcinoma miR-34b miR-155 prognosis
  • 相关文献

参考文献4

二级参考文献40

  • 1Sihoe AD, Van Schil P. Non - small cell lung cancer: When to offersublobar resection[ J]. Lung Cancer,2014,14:371 -377.
  • 2Liu SV,Giaccone G. Lung cancer in 2013 :Refining standard prac-tice and admitting uncertainty [ J]. Nat Rev Clin Oncol,2014,11(2):69 -70.
  • 3Bartels CL,Tsongalis GJ. MicroRNAs:Novel biomarkers for humancancer[ J]. Clin Chem,2009,55(4) :623 -631.
  • 4Visone R,Croce CM. MiRNAs and cancer[ J]. Am J Pathol,2009,174(4) :1131 -1138.
  • 5江文洋,付向宁,廖永德.MiR -200b在肺癌中的表达及临床意义[J].中国医师进修杂志,2012,35(21) :3-5.
  • 6Zhang WC,Liu J,Xu X,et al. The role of microRNAs in lung canc-er progression[ J]. Med Oncol,2013 ,30(3) :675.
  • 7Qi J, Mu D. MicroRNAs and lung cancers: From pathogenesis toclinical implications[ J]. Front Med,2012,6(2) :134 - 155.
  • 8Stella GM, Luisetti M, Pozzi E, et al. Oncogenes in non - small -cell lung cancer : Emerging connections and novel therapeutic dy-namics[ J]. Lancet Respir Med,2013,1 (3) :251 -261.
  • 9Wang R,Ma J,Wu Q,et al. Functional role of miR -34 family inhuman cancer [ J ] . Curr Drug Targets, 2013,14 ( 10 ) : 1185 -1191.
  • 10Wu MY,Fu J, Xiao X,et al. MiR - 34a regulates therapy resist-ance by targeting HDAC1 and HDAC7 in breast cancer[ J]. Canc-er Lett,2014,354(2) :311 -319.

共引文献13

同被引文献51

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部